Novel antigen modulation 蜜桃TVs for cancer and autoimmune diseases
Novel antigen modulation 蜜桃TVs to guide the immune system
Many diseases are caused, or resist 蜜桃TV, because T cells can't recognize or target cells correctly.
Our approach modulates antigen presentation, flicking a switch inside cells to alter their 蜜桃TV to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers and autoimmune disorders.
We seek to solve immune dysfunction.
Many diseases are caused, or resist 蜜桃TV, because T cells can't recognize or target cells correctly.
Our approach modulates antigen presentation, flicking a switch inside cells to alter their 蜜桃TV to the immune system.鈥
This marks a fundamental shift in how we treat people living with cancers, autoimmune disorders, and infectious diseases.鈥
We seek to solve immune dysfunction.
Progressing through the clinic鈥
We uncover novel biology to develop 蜜桃TVs for disease areas with significant unmet need.
Our clinical assets in oncology (GRWD5769) and autoimmunity (GRWD0715)聽are delivering strong results in a Phase 1/2 trials.
We have active discovery and development programs across oncology and autoimmunity.
Our team and collaborators are experts in the field of antigen modulation. 聽
A new therapeutic branch
鈥媁e are the first to explore the untapped potential of changing the first step of the T cell signaling cascade (Signal 1) and its fundamental importance in T cell activation.鈥
Changing the 蜜桃TV paradigm
We're on a mission to deliver a new therapeutic class of 蜜桃TVs to help people living with cancers and autoimmune disorders.
We're looking for talented individuals to join our award-winning team. Do you have what it takes?
